03:28 AM EDT, 06/11/2025 (MT Newswires) -- Mark L. Jacobson, Chief Operating Officer, on June 09, 2025, sold 25,000 shares in Axsome Therapeutics ( AXSM ) for $2,761,000. Following the Form 4 filing with the SEC, Jacobson has control over a total of 5,783 common shares of the company, with 5,783 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1579428/000095017025084556/xslF345X05/ownership.xml